RNF 43 truncations trap CK 1 to drive niche‐independent self‐renewal in cancer
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Wnt/β-catenin signaling is a primary pathway for stem cell maintenance during tissue renewal and a frequent target for mutations in cancer. Impaired Wnt receptor endocytosis due to loss of the ubiquitin ligase RNF43 gives rise to Wnt-hypersensitive tumors that are susceptible to anti-Wnt-based therapy. Contrary to this paradigm, we identify a class of RNF43 truncating cancer mutations that induce β-catenin-mediated transcription, despite exhibiting retained Wnt receptor downregulation. These mutations interfere with a ubiquitin-independent suppressor role of the RNF43 cytosolic tail that involves Casein kinase 1 (CK1) binding and phosphorylation. Mechanistically, truncated RNF43 variants trap CK1 at the plasma membrane, thereby preventing β-catenin turnover and propelling ligand-independent target gene transcription. Gene editing of human colon stem cells shows that RNF43 truncations cooperate with p53 loss to drive a niche-independent program for self-renewal and proliferation. Moreover, these RNF43 variants confer decreased sensitivity to anti-Wnt-based therapy. Our data demonstrate the relevance of studying patient-derived mutations for understanding disease mechanisms and improved applications of precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626 · cited 4×
“…our findings predict differential sensitivity of these RNF43 mutational classes to treatment with PORCN inhibitors, Wnt antagonists that are currently evaluated for clinical treat-ment of RNF43 -mutant cancer patients (Janku et al , 2015; Zhan et al , 2017; Rodon et al , 2018; Zhang & Lum, 2018).”
InfluentialRoux, K. J., Kim, D. I., Raida, M., & Burke, B. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201112098 · Cited by 2,416
A single-cell survey of the small intestinal epithelium
Haber, A. L., Biton, M., Rogel, N., Herbst, R. H., Shekhar, K., Smillie, C., Burgin, G., Delorey, T. M., Howitt, M. R., Katz, Y., et al. (2017) · Nature · doi:10.1038/nature24489 · Cited by 1,750 · cited 2×
“Significantly changed intestinal cell-type gene sets from Haber et al ( 2017 ) are shown (FDR < 0 .”
Sequential cancer mutations in cultured human intestinal stem cells
Drost, J., van Jaarsveld, R. H., Ponsioen, B., Zimberlin, C., van Boxtel, R., Buijs, A., Sachs, N., Overmeer, R. M., Offerhaus, G. J., Begthel, H., et al. (2015) · Nature · doi:10.1038/nature14415 · Cited by 1,067 · cited 2×
“Healthy human colon tissue was isolated to establish human intestinal organoids for a previous study (Drost et al , 2015).”
Self-citationWnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex
Li, V. S. W., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J. R., Maurice, M. M., Mahmoudi, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.002 · Cited by 889 · cited 1×
“…tail are involved in dynamic regulatory interactions with components of the cytosolic destruction complex that are recruited to the receptors under Wnt-stimulated conditions (Fig 5C; Mao et al , 2001; Cliffe et al , 2003; Tamai et al , 2004; Zeng et al , 2005; Bilic et al , 2007; Li et al , 2012).”
Fujii, M., Shimokawa, M., Date, S., Takano, A., Matano, M., Nanki, K., Ohta, Y., Toshimitsu, K., Nakazato, Y., Kawasaki, K., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.003 · Cited by 852 · cited 2×
“…and confer decreased sensitivity to anti-Wnt-based therapy A key feature of cancer pathway driver mutations is their ability to confer niche-independent growth, which is examined by depleting stem cell growth factors from the organoid culture medium (Sato et al , 2011; Fujii et al , 2016).”
Polakis, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008052 · Cited by 847 · cited 2×
“Flag-Dishevelled1 DEP-C, TOPFlash, and FOPFlash luciferase reporter plasmids were described previously (Tauriello et al , 2010, 2012).”
Mao, J., Wang, J., Liu, B., Pan, W., Farr, G. H., Flynn, C., Yuan, H., Takada, S., Kimelman, D., Li, L., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00224-6 · Cited by 839 · cited 1×
“…tail are involved in dynamic regulatory interactions with components of the cytosolic destruction complex that are recruited to the receptors under Wnt-stimulated conditions (Fig 5C; Mao et al , 2001; Cliffe et al , 2003; Tamai et al , 2004; Zeng et al , 2005; Bilic et al , 2007; Li et al , 2012).”
Cited by
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00307-z · Cited by 466
Self-citationWNT as a Driver and Dependency in Cancer
Parsons, M. J., Tammela, T., & Dow, L. E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0190 · Cited by 257
“Recently, Spit et al described a third category of RNF43 truncations within a 50 amino acid region (K514-Q563) in the C-terminal half of the protein (103).”
BackgroundBelenguer, G., Mastrogiovanni, G., Pacini, C., Hall, Z., Dowbaj, A. M., Arnes-Benito, R., Sljukic, A., Prior, N., Kakava, S., Bradshaw, C. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27923-z · Cited by 71
Self-citation
Metadata
- Authors
- Spit, M., Fenderico, N., Jordens, I., Radaszkiewicz, T., Lindeboom, R. G., Bugter, J. M., Cristobal, A., Ootes, L., van Osch, M., Janssen, E., Boonekamp, K. E., Hanakova, K., Potesil, D., Zdrahal, Z., Boj, S. F., Medema, J. P., Bryja, V., Koo, B., Vermeulen, M., & Maurice, M. M.
- Venue
- The EMBO Journal
- Published
- 2020-08-10
- Volume
- 39
- Issue
- 18
- Pages
- e103932-e103932
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W3048286720
- Cited by
- 48
- References
- 12
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RNF 43 truncations trap CK 1 to drive niche‐independent self‐renewal in cancer. https://app.cochat.ai/papers/10.15252/embj.2019103932
- The paper
- Spit, M., Fenderico, N., Jordens, I., Radaszkiewicz, T., Lindeboom, R. G., Bugter, J. M., Cristobal, A., Ootes, L., van Osch, M., Janssen, E., Boonekamp, K. E., Hanakova, K., Potesil, D., Zdrahal, Z., Boj, S. F., Medema, J. P., Bryja, V., Koo, B., Vermeulen, M., & Maurice, M. M. (2020). RNF 43 truncations trap CK 1 to drive niche‐independent self‐renewal in cancer. The EMBO Journal. https://doi.org/10.15252/embj.2019103932
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.